Background: To evaluate a cohort of patients with a suspected beta-lactam allergy history. Methods: 42 patients with suspected beta-lactam hypersensitivity reactions were evaluated at a drug allergy clinic at a tertially allergy center. Skin prick tests (SPT) with major determinants (PPL), minor determinants (MDM), penicillin G, ampicillin, amoxicillin, intradermal tests (ID) and specific IgE determination were done. If all tests were negative, a drug challenge was performed.
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3 Allergy Clinic Lin Medical Center, Haifa, Israel. Background: The "penicillin allergic" label becomes very common, thus preventing from many patients the use of one of the most efficient antibiotic drugs, with the lowest cost and toxic effects. However, approximately 80% of patients with a history of penicillin allergy have negative results if they are skin tested and can actually use this drug class. We sought to determine whether in real life, removal of the label is implemented to the treatment of beta-lactams when it is required. Methods: A retrospective study that includes all penicillin allergy historypositive/penicillin skin test-negative/oral amoxicillin challenge-non reactive individuals who had been tested in advance of need between the years 2000 toi 2009 at one medical center (n ¼ 140). To uncover late reactions, they were offered after the test a 5 day course of amoxicillin. The study tool was a phone-questionnaire assessing the patients' confidence in their test results, and whether they have used penicillin since testing. Results: 106 patients (76%) agreed to participate in the survey. Ninety-nine patients (93%) chose to take the 5 day course of amoxicillin. From this group of patients twenty-seven (27.2%) answered that they feel intermediate insecurity and fourteen (14.1%) that they feel complete insecurity to receive penicillin. Since having the test seventy 2 (72.7%) of the 99 needed penicillin. Sixty-two (86.1%) indeed took a beta-lactam while 10 patients (13.9%) chose to receive another antibiotic class due to their or their physician's disbelief in the test. All the patients (n ¼ 7) who chose not to take the course of amoxicillin after the test stated that they feel complete insecurity to receive penicillin. Four (57.1%) of these patients had a disease that requires a beta-lactam antibiotic and actually, none of them agreed to take one (P ¼ 0.01). Conclusions: A negative penicillin test done in advance of need even when includes an oral challenge may not be enough to convince patients that they can use beta-lactams. Our study suggests that giving a 5 day course of amoxicillin after the test increases the patients' confidence in the results. Policlinica Geral do Rio de Janeiro, Rio de Janeiro, Brazil. Background: Hypersensitivity to beta-lactam antibiotics are usually defined only by the history of suspected previous reaction to these medicines. This definition, however, can erroneously restrict the use of these important therapeutic resources if not assessed by the proper tests. The objective was to assess the presence of hypersensitivity to beta-lactams through adequate testing. Methods: Thirty-three patients were referred to our allergic clinic for testing of penicillin hypersensitivity in the period from 2008 to 2011: 22 (66.6%) females and 11 (33.4%) males, with ages ranging from 8 to 88 years. The first 24 (72.7%) patients were tested using only penicillin G, in the form of a prick test followed by an intradermal test with immediate reading, according to the Brazil Ministry of Health protocol (group I). The remaining 9 (27.3%) patients (group II) were subjected to the adaptations of standards-based assessment of hypersensitivity reactions to beta-lactam antibiotics, according to the algorithmic recommendations of the European Network Drug Allergy (ENDA), which includes a prick test and intradermal test with penicillin G, amoxicillin and the suspected beta-lactam, such as clavulanic acid or cephalosporins, with immediate and delayed readings. Patients who had negative skin tests results underwent a provocation test, which is considered the gold standard in determining drug hypersensitivity. In-vitro tests available in Brazil (specific IgE to penicillin and amoxicillin) were performed in patients with a history more suggestive of adverse reactions. It was respected the ENDA recommendation of not subjecting patients with severe reactions to this protocol. 
